Tactile Systems Technology (TCMD) Operating Income (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.17% |
| Dec 31, 2025 | 71.26% |
| Sep 30, 2025 | 168.50% |
| Jun 30, 2025 | 189.89% |
| Mar 31, 2025 | 4.04% |
| Dec 31, 2024 | -169.80% |
| Sep 30, 2024 | 15.93% |
| Jun 30, 2024 | 297.33% |
| Mar 31, 2024 | -0.92% |
| Dec 31, 2023 | -136.76% |
| Sep 30, 2023 | 288.19% |
| Jun 30, 2023 | 154.07% |
| Mar 31, 2023 | -148.48% |
| Dec 31, 2022 | 584.57% |
| Sep 30, 2022 | 60.36% |
| Jun 30, 2022 | 72.57% |
| Mar 31, 2022 | -495.78% |
| Dec 31, 2021 | 375.42% |
| Sep 30, 2021 | -1,698.68% |
| Jun 30, 2021 | 98.14% |
| Mar 31, 2021 | -158.42% |
| Dec 31, 2020 | 289.69% |
| Sep 30, 2020 | 122.53% |
| Jun 30, 2020 | -78.90% |
| Mar 31, 2020 | -173.58% |
| Dec 31, 2019 | 88.85% |
| Sep 30, 2019 | 5.09% |
| Jun 30, 2019 | 269.15% |
| Mar 31, 2019 | -184.36% |
| Dec 31, 2018 | 55.91% |
| Sep 30, 2018 | 4.50% |
| Jun 30, 2018 | 171.76% |
| Mar 31, 2018 | -137.08% |
| Dec 31, 2017 | 291.65% |
| Sep 30, 2017 | 72.33% |
| Jun 30, 2017 | 124.90% |
| Mar 31, 2017 | -189.06% |
| Dec 31, 2016 | 237.99% |
| Sep 30, 2016 | -45.65% |
| Jun 30, 2016 | 200.34% |
| Mar 31, 2016 | -155.04% |
| Dec 31, 2015 | 121.96% |
| Sep 30, 2015 | 541.23% |